Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Label-free fiber-optic cascade sensor for rapid and ultrasensitive serum folate quantification. | Talanta | 2027 | 42691716 | PubTator, text mining | PubMed |
| DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy. | Antib Ther | 2026 | 42824820 | PubTator, text mining | PubMed |
| Biomarker-Driven Treatments for Ovarian Cancer: Moving Beyond HRD? | Int J Womens Health | 2026 | 42824309 | PubTator, text mining | PubMed |
| An integrated microfluidic platform for tunable-stringency competitive affinity selection of folate receptor alpha aptamers. | Lab Chip | 2026 | 42820463 | PubTator, text mining | PubMed |
| Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques. | Geroscience | 2026 | 42799938 | PubTator, text mining | PubMed |
| Prenatal Folinic Acid in FRAA-Positive Pregnancies: Preschool Neurodevelopmental Outcomes from a Pilot RCT Follow-Up. | Nutrients | 2026 | 42796952 | PubTator, text mining | PubMed |
| Search for leukemia-restricted targets: a new paradigm for precision immunotherapy in acute myeloid leukemia. | Haematologica | 2026 | 42779343 | PubTator, text mining | PubMed |
| Near-Infrared Fluorescent Zwitterionic Folic Acid Probe and Serum CA125 for Enhancing Diagnostic Accuracy of Malignant Ovarian Cancer Ascites. | Technol Cancer Res Treat | 2026 | 42753264 | PubTator, text mining | PubMed |
| Post-marketing safety assessment of mirvetuximab soravtansine: a disproportionality analysis based on the FDA Adverse Event Reporting System. | J Gynecol Oncol | 2026 | 42750304 | PubTator, text mining | PubMed |
| Comparative Transcriptomic and Immune Profiling Reveals a Shared Molecular Identity Between Clear Cell Odontogenic Carcinoma and Hyalinizing Clear Cell Carcinoma. | Mol Cancer Res | 2026 | 42743086 | PubTator, text mining | PubMed |
| T-Cell Engagers in Lung Cancer: A Comprehensive Literature Review from Tarlatamab Approval to Next-Generation Strategies. | Cancers (Basel) | 2026 | 42738247 | PubTator, text mining | PubMed |
| Corrigendum to: FOLR1 Regulates the Malignant Progression of Glioblastoma through the SRC/ERK1/2 Axis. | Comb Chem High Throughput Screen | 2026 | 42734236 | PubTator, text mining | PubMed |
| Real-world outcomes after Mirvetuximab Soravtansine treatment for recurrent ovarian Cancer: Results from a university setting. | Gynecol Oncol Rep | 2026 | 42733650 | PubTator, text mining | PubMed |
| Characterizing features of the genetic architecture underlying autism from a multi-ancestry perspective. | Mol Psychiatry | 2026 | 42728317 | PubTator, text mining | PubMed |
| Folate in autism neurodevelopment. | Front Nutr | 2026 | 42689097 | PubTator, text mining | PubMed |
| Folate Receptor Alpha Expression Across the Spectrum of Serous Tubal Lesions: An Adjunct Biomarker for Distinguishing Serous Tubal Intraepithelial Carcinoma From Serous Tubal Intraepithelial Lesions. | Am J Surg Pathol | 2026 | 42679176 | PubTator, text mining | PubMed |
| Cerebral folate deficiency, developmental difficulties in autism spectrum disorder and the role of leucovorin: a narrative review of mechanisms and clinical evidence. | Drugs Context | 2026 | 42662924 | PubTator, text mining | PubMed |
| Exosome-Associated Proteins as Mediators and Biomarkers of Ovarian Cancer Dissemination. | Biomolecules | 2026 | 42650816 | PubTator, text mining | PubMed |
| Retinal Biomarkers of Folate and Vitamin B12 Metabolic Dysfunction: A Framework for Machine Learning-Assisted Detection of Cerebral Folate Deficiency. | Cells | 2026 | 42645181 | PubTator, text mining | PubMed |
| Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers. | Int J Gynecol Cancer | 2026 | 42642279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers